期刊文献+

粉尘螨疫苗治疗变应性鼻炎患者的依从性及相关因素分析 被引量:13

The compliance of the dust mite vaccine in treating allergia rhinitis and its relevance factors
原文传递
导出
摘要 目的研究变应性鼻炎粉尘螨疫苗舌下含服免疫治疗1年后患者的依从性及其影响因素。方法对过去1年接受粉尘螨免疫治疗的变应性鼻炎患者进行回顾性调查。对治疗脱落的患者采取电话方式了解其不依从的原因,并做率的比较,采用χ2检验进行分析。结果粉尘螨疫苗治疗患者的依从率为70.19%。儿童的依从率为84.60%,高于成人的62.75%,差异有统计学意义(χ2=5.517,P<0.05)。不依从的原因调查表明,效果不明显或无效占22.92%,症状消失或好转占20.83%,工作忙或学业紧张占16.67%。结论变应性鼻炎特异性免疫治疗患者的依从性不理想,儿童的依从性高于成人。调查结果提示治疗中如有针对性地采用相应的干预措施,可以提高患者免疫治疗的依从率,从而提高疗效。 Objective In order to know the compliance of sublingual immunotherapy in 1 year with allergic diseases and identify factors that may influence compliance.Methods Patients were contacted with scheduled telephone interviews at the 12 months of therapy and asked to count at that moment the remaining vials.Results The compliance rate of SLIT with mites was 70.19%,the rate in children was 84.6% higher than 62.75% in adults(χ2=5.517,P0.05).The factors of un compliance:uneffective(22.92%),effective(20.83%),work and study(16.67%).Conclusion The compliance of sublingual immunotherapy at home is unsatisfactory,intervention can efectively improve the compliance of patients with allergic diseases when cured by SLIT and improve effecacy.
出处 《临床医学》 CAS 2010年第7期30-32,共3页 Clinical Medicine
关键词 变应性鼻炎 粉尘螨疫苗治疗 依从性 Allergic rhinitics SLIT Compliance
  • 相关文献

参考文献12

二级参考文献110

  • 1冉茂盛.精神病人治疗的依从性[J].华西医学,1994,9(1):16-19. 被引量:6
  • 2唐镜波,陈香谱,谭军,车艳.合理用药调研的国际指标[J].中国药房,1995,6(4):5-7. 被引量:176
  • 3崔清江,史俊义.儿科合理用药与患儿家长的依从性[J].药学实践杂志,1996,14(6):365-366. 被引量:5
  • 4刘贤臣.论病人的依从性[J].国外医学:社会医学分册,1988,5(4):237-237.
  • 5李明华.变应原免疫治疗的近代研究[J].中华微生物学和免疫学杂志,1992,12:60-60.
  • 6李明华.变应性哮喘治疗研究进展[J].中华微生物学和免疫学杂志,1996,16:96-96.
  • 7彭志松,王祥,王凯萍,殷凯生.脱敏治疗对过敏性哮喘患者外周血Th1/Th2细胞表达的影响[J].江苏医药,2007,33(8):796-797. 被引量:7
  • 8Wilson DR, Nouri-Aria KT, Walker SM, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol, 2001,107 (6) : 971-976.
  • 9Gabrielsson S, Soderlund A, Paulie S, et al. Specific immunotherapy prevents increased levels of allergen-specefec IL-4 and IL-13 producing cells during pollen season. Allergy, 2001,56(4) : 293-300.
  • 10Erel F, Kataayvaz M, Caliskaner AZ, et al. Effects of allergen immunotherapy on the nasal mucosa in patients with allergic rhinitis. J Invesrig Allergol Clin Immunol, 2000, 10( 1): 14-19.

共引文献1785

同被引文献89

引证文献13

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部